| Literature DB >> 31752820 |
Florien Margareth Kruse1, M C van Nieuw Amerongen2, I Borghans2, A S Groenewoud3, E Adang4, P P T Jeurissen3,5.
Abstract
BACKGROUND: The number of independent treatment centres (ITCs) has grown substantially. However, little is known as to whether the volume-quality relationship exists within this sector and whether other possible organisational factors mediate this relationship. The aim of this study is to gain a better understanding of such possible relationships.Entities:
Keywords: Independent treatment centres; Outpatient procedures; Quality of care; Volume
Mesh:
Year: 2019 PMID: 31752820 PMCID: PMC6868751 DOI: 10.1186/s12913-019-4467-5
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
The seven structural and process quality indicators
| Whether an independent treatment centre… | |
|---|---|
| is reachable 24/7 | |
| has a system whereby the performance of their personnel is reviewed | |
| has an arrangement in place for dysfunctional personnel | |
| uses a questionnaire that inquires patient reported experiences or outcomes | |
| classified the American Society of Anesthesiologists (ASA) physical status (i.e. severity) of their patients | |
| screened for delirium | |
| has a collaboration with (a) hospital(s) |
Summary statistics 2014–2017
| Overall mean ± SD | Between SD | Within SD | N (n) | |
|---|---|---|---|---|
| Characteristics ITCs | ||||
| Number of invasive treatments | 1571.85 ± 1881.56 | 1693.96 | 819.81 | 941 (338) |
| FTE physicians | 2.32 ± 2.45 | 2.35 | 1.04 | 941 (338) |
| FTE nurses | 1.49 ± 3.55 | 3.34 | 1.14 | 941 (338) |
| Number of locations | 2.61 ± 3.11 | 2.73 | 0.82 | 941 (338) |
| Chain membership | 0.40 ± 0.49 | 0.47 | 0.16 | 941 (338) |
| Non-profit providers | 0.68 ± 0.47 | 0.47 | 0.00 | 941 (338) |
| Composite Quality indicators | ||||
| Reachable 24/7 | 0.67 ± 0.47 | 0.31 | 0.40 | 716 (313) |
| Personnel functioning system | 0.78 ± 0.41 | 0.38 | 0.21 | 716 (313) |
| Personnel malfunctioning system | 0.78 ± 0.41 | 0.36 | 0.22 | 716 (313) |
| Patient satisfactory questionnaire | 0.88 ± 0.33 | 0.32 | 0.16 | 716 (313) |
| ASA classification known | 0.48 ± 0.50 | 0.46 | 0.21 | 716 (313) |
| Screening delirium | 0.34 ± 0.48 | 0.42 | 0.23 | 716 (313) |
| Collaboration with (a) hospital(s) | 0.64 ± 0.48 | 0.45 | 0.20 | 716 (313) |
| Structural and process composite | −0.00 ± 3.31 | 3.19 | 1.48 | 716 (313) |
| Quality outcomes | ||||
| Percentage infections | 0.28 ± 1.14 | 0.96 | 0.79 | 877 (318) |
| Percentage infections (> 0 postoperative infections & > =50 invasive treatments) | 0.47 ± 0.62 | 0.65 | 0.29 | 412 (189) |
| Average patient satisfaction score | 8.74 ± 1.17 | 0.40 | 1.12 | 19,338 (80) |
| Ratio promoters over total number of observations per provider | 0.52 ± 0.50 | 0.17 | 0.47 | 19,338 (80) |
| Ratio detractors over total number of observations per provider | 0.03 ± 0.17 | 0.04 | 0.17 | 19,338 (80) |
| Ratio 7 or more over total number of observations per provider | 0.95 ± 0.22 | 0.04 | 0.21 | 19,338 (80) |
| Ratio 8 or more over total number of observations per provider | 0.84 ± 0.36 | 0.09 | 0.35 | 19,338 (80) |
| Net Promoter Score (in ratio) | 0.55 ± 0.19 | 0.19 | 0.06 | 118 (55) |
| Control variables | ||||
| Specialism ophthalmology | 0.23 ± 0.42 | 0.39 | 0.07 | 941 (338) |
| Specialism dermatology | 0.37 ± 0.48 | 0.47 | 0.13 | 941 (338) |
| Specialism orthopaedics | 0.11 ± 0.31 | 0.31 | 0.05 | 941 (338) |
| Specialism aesthetic surgery | 0.59 ± 0.49 | 0.47 | 0.18 | 941 (338) |
| Ratio ASA II over total number of patients | 0.13 ± 0.16 | 0.14 | 0.08 | 622 (241) |
| Ratio ASA III over total number of patients | 0.01 ± 0.06 | 0.04 | 0.04 | 623 (242) |
| Robustness check | ||||
| Number of aesthetic invasive treatments | 502.40 ± 1269.82 | 972.17 | 844.36 | 488 (211) |
| Percentage infections after aesthetic surgery | 0.90 ± 6.81 | 7.76 | 4.16 | 449 (182) |
AIC scores
| Linear | SQRT | Cubic | Logarithmic | |
|---|---|---|---|---|
| Structural and process composite | 2152 | 2147 | 2144 | 2138 |
| Postoperative infections | 377.4 | 352.0 | 339.9 | 311.7 |
| Pooled data - postoperative infections | 40.90 | 39.10 | 38.60 | 38.30 |
| Aesthetic postoperative infections | 408.6 | 403.7 | 400.5 | 393.5 |
| Patients ratings – mean score | 59,435 | 59,433 | 59,432 | 59,430 |
| NPS | − 128.1 | −128.2 | −128.3 | −128.5 |
Fig. 1Visualisation non-linear volume-quality relationship
Relationship between the composite structural and process quality indicators or postoperative infections and ITC characteristics
| Model I | Model II | Model III | Model IV | |
|---|---|---|---|---|
| Composite structural and process quality indicator | Percentage postoperative infections | Percentage postoperative infections | Percentage postoperative infections | |
| RE-Linear | RE-Linear | RE-Linear | RE-Linear | |
| Annual data | Annual data | Total over 3 years | Annual data | |
| Log invasive treatments | 0.418*** (0.089) | −0.339*** (0.033) | −0.094*** (0.031) | |
| Highest quantile invasive treatments | Reference | |||
| Higher medium quantile invasive treatments | 0.029 (0.096) | |||
| Lower medium quantile invasive treatments | 0.169 (0.107) | |||
| Lowest quantile invasive treatments | 0.293*** (0.114) | |||
| FTE number of professionals | 0.009 (0.034) | 0.010 (0.006) | 0.011* (0.006) | 0.009 (0.009) |
| No chain membership | Reference | Reference | Reference | Reference |
| Chain membership | −0.393 (0.302) | 0.116* (0.063) | − 0.130 (0.090) | − 0.100 (0.074) |
| For-profit | Reference | Reference | Reference | Reference |
| Non-profit | 0.449 (0.363) | 0.028 (0.073) | 0.174** (0.075) | 0.187** (0.087) |
| ID ITC | ID ITC | ID Chain | ID ITC | |
| 459 | 292 | 112 | 596 | |
| 211 | 145 | 72 | 236 |
Corrected for type of specialism, case-mix (i.e. ASA II & III) and year effects (except for the pooled data)
***p < 0.01, **p < 0.05, *p < 0.1
Relationship between patient ratings and ITC characteristics
| Type of outcome variable | Mean score | Promoter (> = 9) | Ratings > = 7 | Ratings > = 8 | Detractor (<=6) | NPS |
|---|---|---|---|---|---|---|
| Type of model | RE-Linear | RE-Logit | RE-Logit | RE-Logit | RE-Logit | RE-Linear |
| Log invasive treatments | −0.073* (0.035) | −0.123* (0.071) | −0.103 (0.121) | −0.174* (0.099) | 0.182 (0.151) | 0.027 (0.025) |
| FTE number of professionals | 0.002 (0.003) | 0.007 (0.006) | 0.008 (0.012) | 0.014 (0.009) | −0.013 (0.016) | −0.00 (0.002) |
| No chain membership | Reference | Reference | Reference | Reference | Reference | Reference |
| Chain membership | −0.163* (0.089) | −0.133 (0.184) | − 0.409* (0.238) | −0.390* (0.212) | 0.504* (0.293) | −0.077* (0.047) |
| For-profit | Reference | Reference | Reference | Reference | Reference | Reference |
| Non-profit | −0.133 (0.114) | −0.365 (0.233) | − 0.355 (0.361) | −0.446 (0.288) | 0.037 (0.429) | −0.178*** (0.061) |
| Level of measurement | Patient level | Patient level | Patient level | Patient level | Patient level | Provider level |
| Cluster | ID ITC + ID Chain | ID ITC + ID Chain | ID ITC + ID Chain | ID ITC + ID Chain | ID ITC + ID Chain | ID Chain |
| Observations | 16,507 | 16,507 | 16,507 | 16,507 | 16,507 | 97 |
| Number of groups | 68 | 68 | 68 | 68 | 68 | 46 |
Corrected for case-mix (ASA II & III), type of treatment and year
***p < 0.01, < 0.05, *p < 0.1
Robustness check with fractional logit models and aesthetic invasive treatments
| Model I | Model II | Model III | |
|---|---|---|---|
| Proportional postoperative infections | Proportional postoperative infections | Percentage postoperative infections – aesthetic surgery | |
| Fractional logit | Fractional logit | RE-Linear | |
| Annual data | Annual data | Annual data | |
| Log invasive treatments | −0.226** (0.111) | −0.566*** (0.135) | |
| Highest quantile invasive treatments | Reference | ||
| Higher medium quantile invasive treatments | 0.279 (0.193) | ||
| Lower medium quantile invasive treatments | 0.869*** (0.236) | ||
| Lowest quantile invasive treatments | 1.321*** (0.452) | ||
| FTE number of professionals | 0.029 (0.021) | 0.056*** (0.021) | 0.012 (0.033) |
| No chain membership | Reference | Reference | Reference |
| Chain membership | −0.188 (0.215) | −0.550* (0.318) | 0.755** (0.317) |
| For-profit | Reference | Reference | Reference |
| Non-profit | 0.558* (0.310) | 0.782** (0.339) | −0.226 (0.319) |
| ID ITC | ID ITC | ID ITC | |
| 555 | 596 | 113 |
Corrected for case-mix (ASA II & III), type of treatment (except Model III since it only includes aesthetic surgery) and year
****p < 0.01, **p < 0.05, *p < 0.1